Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 311 recruiting studies, sorted by proximity — each links to its official registry page
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Hartford Healthcare Cancer Institute @ Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: SWOG Cancer Research Network
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mercy Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Baystate Medical Center — Springfield, Massachusetts (2.8 mi)
· Sponsor: NRG Oncology
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Spinal Disease, Degenerative Disc Disease
N/A
Observational 120 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Collagen Matrix
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
Anterior Cruciate Ligament Reconstruction
N/A
Interventional 40 participants sought
University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
Hemiplegia, Cerebral Palsy
N/A
Interventional 30 participants sought
Physical Therapy Program, Department of Kinesiology, University of Connecticut — Storrs, Connecticut (25.9 mi)
· Sponsor: University of Connecticut
CLOZAPINE Response in Biotype-1
Schizophrenia, Schizoaffective Disorder
Phase 4
Interventional 524 participants sought
Hartford Healthcare — Hartford, Connecticut (25.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Starling Physicians — Hartford, Connecticut (25.4 mi)
· Sponsor: Pfizer
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Elixia MA, LLC — Springfield, Massachusetts (2.8 mi)
· Sponsor: Teikoku Pharma USA, Inc.
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hoffmann-La Roche
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Janssen Research & Development, LLC
I-DECIDE After Bronchiolitis Hospitalization
Bronchiolitis Acute
N/A
Interventional 2,700 participants sought
Baystate Children's Hospital — Springfield, Massachusetts (2.8 mi)
· Sponsor: Seattle Children's Hospital
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Elixia SISU BHR - Sprinfield — Springfield, Massachusetts (2.8 mi)
· Sponsor: Ardelyx
Multifidus Cervicis Plane Block Vs. Sham Block For Posterior Cervical Spine Fusion Surgery
Cervical Spine Fusion
Phase 4
Interventional 38 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Hartford Hospital
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Smilow Cancer Hospital Care Center at Saint Francis — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Neuroblastoma, Ewing Sarcoma
Phase 1, Phase 2
Interventional 104 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Milton S. Hershey Medical Center
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Hartford, Connecticut (25.4 mi)
· Sponsor: Alkermes, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: Children's Oncology Group
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Pulmonary Hypertension, Interstitial Lung Disease
N/A
Observational 80 participants sought
Hartford Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Liquidia Technologies, Inc.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Springfield, Massachusetts (2.8 mi)
· Sponsor: Axsome Therapeutics, Inc.
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Hartford, Connecticut (25.4 mi)
· Sponsor: Ecotera Health LLC
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Connecticut Children's Hospital — Hartford, Connecticut (25.4 mi)
· Sponsor: Giselle Sholler
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Connecticut Children's Medical Center — Hartford, Connecticut (25.4 mi)
· Sponsor: National Cancer Institute (NCI)